000 01829 a2200541 4500
005 20250515224743.0
264 0 _c20101104
008 201011s 0 0 eng d
022 _a1432-0428
024 7 _a10.1007/s00125-010-1795-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFriedrichsen, M
245 0 0 _aDifferential aetiology and impact of phosphoinositide 3-kinase (PI3K) and Akt signalling in skeletal muscle on in vivo insulin action.
_h[electronic resource]
260 _bDiabetologia
_cSep 2010
300 _a1998-2007 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Twin Study
650 0 4 _aAdult
650 0 4 _aAge Factors
650 0 4 _aBirth Weight
_xphysiology
650 0 4 _aBlotting, Western
650 0 4 _aFemale
650 0 4 _aGlucose
_xmetabolism
650 0 4 _aGlucose Clamp Technique
650 0 4 _aHumans
650 0 4 _aInsulin
650 0 4 _aInsulin Receptor Substrate Proteins
_xmetabolism
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMuscle, Skeletal
_xdrug effects
650 0 4 _aObesity
_xphysiopathology
650 0 4 _aPhosphatidylinositol 3-Kinases
_xmetabolism
650 0 4 _aProto-Oncogene Proteins c-akt
_xmetabolism
650 0 4 _aReceptor, Insulin
_xmetabolism
650 0 4 _aSex Factors
650 0 4 _aSignal Transduction
_xdrug effects
700 1 _aPoulsen, P
700 1 _aRichter, E A
700 1 _aHansen, B F
700 1 _aBirk, J B
700 1 _aRibel-Madsen, R
700 1 _aStender-Petersen, K
700 1 _aNilsson, E
700 1 _aBeck-Nielsen, H
700 1 _aVaag, A
700 1 _aWojtaszewski, J F P
773 0 _tDiabetologia
_gvol. 53
_gno. 9
_gp. 1998-2007
856 4 0 _uhttps://doi.org/10.1007/s00125-010-1795-8
_zAvailable from publisher's website
999 _c19864170
_d19864170